XENERA-1: a Randomised Double-Blind Phase Ii Trial of Xentuzumab in Combination with Everolimus and Exemestane Versus Everolimus and Exemestane in Patients with Hormone Receptor-Positive/Her2-Negative Metastatic Breast Cancer and Non-Visceral Disease

AuthID
P-00Y-MBE
16
Author(s)
Cortes, J
·
Joaquim, A
·
Janez, NM
·
Morales, S
·
Diaz-Redondo, T
·
Neven, P
·
Lemieux, J
·
Garcia-Saenz, JA
·
Massey, D
·
Burris, HA
·
Document Type
Article
Year published
2023
Published
in BREAST CANCER RESEARCH, ISSN: 1465-5411
Volume: 25, Issue: 1
Indexing
Publication Identifiers
Pubmed: 37308971
Scopus: 2-s2.0-85161871307
Wos: WOS:001012809300001
Source Identifiers
ISSN: 1465-5411
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.